{"id":538627,"date":"2021-04-14T19:38:01","date_gmt":"2021-04-14T19:38:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=538627"},"modified":"2021-04-14T19:38:01","modified_gmt":"2021-04-14T19:38:01","slug":"tardive-dyskinesia-pipeline-insight-2021-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/tardive-dyskinesia-pipeline-insight-2021-by-delveinsight_538627.html","title":{"rendered":"Tardive Dyskinesia Pipeline Insight 2021 by DelveInsight"},"content":{"rendered":"
\"Tardive<\/a><\/div>\n

“Tardive Dyskinesia Pipeline<\/a><\/span>” report has been added to DelveInsight<\/strong><\/p>\n

 <\/p>\n

Tardive Dyskinesia<\/strong> Pipeline analysis across different stages of development (Phase III & Phase II), different emerging trends and comparative analysis of Tardive Dyskinesia <\/strong>pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities<\/p>\n

 <\/p>\n

Download free sample copy here- https:\/\/www.delveinsight.com\/sample-request\/tardive-dyskinesia-pipeline-insight <\/a><\/span><\/strong><\/p>\n

 <\/p>\n

Tardive Dyskinesia Pipeline- Overview<\/strong><\/p>\n

Tardive dyskinesia (TD) is an involuntary neurological movement disorder caused by the use of dopamine receptor blocking drugs that are prescribed to treat certain psychiatric or gastrointestinal conditions. Long-term use of these drugs may produce biochemical abnormalities in the area of the brain known as the striatum. The reasons that some people who take these drugs may get tardive dyskinesia, and some people do not, is unknown. Tardive dystonia is a more severe form of tardive dyskinesia in which slower twisting movements of the neck and trunk muscles are prominent.<\/p>\n

 <\/p>\n

Tardive Dyskinesia Pipeline Report<\/strong><\/a><\/span><\/p>\n

TD is characterized by involuntary and abnormal movements of the jaw, lips and tongue. Typical symptoms include facial grimacing, sticking out the tongue, sucking or fish-like movements of the mouth. In some cases, patients also have irregular movement of the trunk and limbs. These movements are typically choreiform or choreoathetoid in type; although, athetosis of the extremities and axial and limb dystonia are often listed as part of the syndrome, as are gait and trunk posture abnormalities, such as rocking or rotary pelvic movements.<\/p>\n

 <\/p>\n

Tardive Dyskinesia Treatment<\/strong><\/a><\/span><\/p>\n

Treatment of tardive dyskinesia initially consists of discontinuing the neuroleptic drug as soon as involuntary facial, neck, trunk, or extremity movements are identified in people taking neuroleptic drugs if this is felt to be safe psychiatrically.<\/p>\n

 <\/p>\n

Tardive Dyskinesia<\/strong> Diagnosis<\/strong><\/p>\n

Tardive dyskinesia is a clinical diagnosis, meaning that there are no blood tests, X-rays, or other objective assessments which can confirm this condition. Physicians often use the Abnormal Involuntary Movement Scale (AIMS) to quantify movements, which appear to be tardive dyskinesia. This scale is a numeric score that grades involuntary movements from 0-4 in 10 different areas, including muscles of facial expression, lips\/perioral area, jaw, tongue, upper extremities, lower extremities, neck, shoulders, hips, severity of overall movements, and patient awareness of the movements.<\/p>\n

 <\/p>\n

Tardive Dyskinesia Causes<\/strong><\/p>\n

In many patients, TD is irreversible and can persist long after the medications that may be causing the symptoms are stopped. Of course, patients need to take the medications that are causing the unwanted side effect of TD; therefore, stopping the medication can be dangerous and may even induce further complications.<\/p>\n

 <\/p>\n

Tardive Dyskinesia Report Highlights<\/strong><\/p>\n